Similar articles

Abstract: This study was designed to investigate the therapeutic approaches and prognosis for cervical cancer associated with pregnancy. Clinical information, therapeutic strategies, and follow-up results of 20 patients with cervical cancer associated with pregnancy from Jan. 2000 to June 2009 in the Zhejiang Cancer Hospital were retrospectively analyzed. The International Federation of Gynecology and Obstetrics (FIGO) stages were: in situ (n=1), stage IA1 (n=1), stage IB1 (n=5), stage IB2 (n=1), stage IIA (n=8), stage IIB (n=3), and stage IIIB (n=1). Eight patients were in the first trimester of pregnancy, four in the second, two in the third, and six at postpartum when diagnosed. The therapeutic strategies were either single or combined modalities, including surgery, radiotherapy, and chemotherapy. Fourteen patients survived, five patients died (four of remote metastasis and one of uremia), and one patient was lost to follow-up. One newborn from a patient at stage IIA carcinoma in the third trimester with postponed therapy six weeks after diagnosis survived. Retarded fetal growth was observed in one patient receiving neoadjuvant chemotherapy and cesarean section. Out of the six postpartum patients, three underwent cesarean section and survived, whereas only one out of the three who underwent vaginal delivery survived. The remaining two died of remote metastasis. Therefore, personalized treatment is necessary for cervical cancer associated with pregnancy. cervical cancer patients in the third trimester of pregnancy can continue the pregnancy for a short period of time. There may be potential risk for the fetus by chemotherapy during pregnancy. Cesarean section is the preferred mode of delivery for pregnant cervical cancer patients.

妊娠相关性宫颈癌20例临床分析

[1]Alouini, S., Rida, K., Mathevet, P., 2008. Cervical cancer complicating pregnancy: implications of laparoscopic lymphadenectomy. Gynecol. Oncol., 108(3):472-477.

[2]Amant, F., van Calsteren, K., Halaska, M.J., et al., 2009. Gynecologic cancers in pregnancy: guidelines of an international consensus meeting. Int. J. Gynecol. Cancer, 19(Suppl. 1):S1-S12.

[3]Benhaim, Y., Pautier, P., Bensaid, C., et al., 2008. Neoadjuvant chemotherapy for advanced stage cervical cancer in a pregnant patient: report of one case with rapid tumor progression. Eur. J. Obstet. Gynecol. Reprod. Biol., 136(2):267-268.

[4]Boyd, A., Cowie, V., Gourley, C., 2009. The use of cisplatin to treat advanced-stage cervical cancer during pregnancy allows fetal development and prevents cancer progression: report of a case and review of the literature. Int. J. Gynecol. Cancer, 19(2):273-276.

[5]Caluwaerts, S., van Calsteren, K., Mertens, L., et al., 2006. Neoadjuvant chemotherapy followed by radical hysterectomy for invasive cervical cancer diagnosed during pregnancy: report of a case and review of the literature. Int. J. Gynecol. Cancer, 16(2):905-908.

[6]Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration, 2008. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J. Clin. Oncol., 26(35):5802-5812.

[7]Chun, K.C., Kim, D.Y., Kim, J.H., et al., 2010. Neoadjuvant chemotherapy with paclitaxel plus platinum followed by radical surgery in early cervical cancer during pregnancy: three case reports. Jpn. J. Clin. Oncol., 40(7):694-698.

[8]Favero, G., Chiantera, V., Oleszczuk, A., et al., 2010. Invasive cervical cancer during pregnancy: laparoscopic nodal evaluation before oncologic treatment delay. Gynecol. Oncol., 118(2):123-127.

[9]Fruscio, R., Villa, A., Chiari, S., et al., 2012. Delivery delay with neoadjuvant chemotherapy for cervical cancer patients during pregnancy: a series of nine cases and literature review. Gynecol. Oncol., 126(2):192-197.

[10]Germann, N., Haie-Meder, C., Morice, P., et al., 2005. Management and clinical outcomes of pregnant patients with invasive cervical cancer. Ann. Oncol., 16(3):397-402.

[11]Greer, B.E., Easterling, T.R., Mclennan, D.A., et al., 1989. Fetal and maternal considerations in the management of stage I-B cervical cancer during pregnancy. Gynecol. Oncol., 34(1):61-65.

[12]Guo, Q., Shan, Y., Yang, J.X., et al., 2012. Management of invasive cervical cancer in pregnancy: clinical analysis of 13 cases. Chin. J. Obstet. Gynecol., 47(12):893-897 (in Chinese).

[13]Hunter, M.I., Tewari, K., Monk, B.J., 2008. Cervical neoplasia in pregnancy. Part 2: current treatment of invasive disease. Am. J. Obstet. Gynecol., 199(1):10-18.

[14]Lai, C.H., Hsueh, S., Chang, T.C., et al., 1997. Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy. Gynecol. Oncol., 64(3):456-462.

[15]Lee, J.M., Lee, K.B., Kim, Y.T., et al., 2008. Cervical cancer associated with pregnancy: results of a multicenter retrospective Korean study (KGOG-1006). Am. J. Obstet. Gynecol., 198(1):92.e1-92.e6.

[16]Lee, R.B., Neglia, W., Park, R.C., 1981. Cervical carcinoma in pregnancy. Obstet. Gynecol., 58(5):584-589.

[17]Marana, H.R., de Andrade, J.M., da Silva Mathes, A.C., et al., 2001. Chemotherapy in the treatment of locally advanced cervical cancer and pregnancy. Gynecol. Oncol., 80(2):272-274.

[18]Morice, P., Uzan, C., Uzan, S., 2012. Cancer in pregnancy: a challenging conflict of interest. Lancet, 379(9815):495-496.

[19]Nisker, J.A., Shubat, M., 1983. Stage IB cervical carcinoma and pregnancy: report of 49 cases. Am. J. Obstet. Gynecol., 145(2):203-206.

[20]Noordhuis, M.G., Eijsink, J.J., Roossink, F., et al., 2011. Prognostic cell biological markers in cervical cancer patients primarily treated with (chemo) radiation: a systematic review. Int. J. Radiat. Oncol. Biol. Phys., 79(2):325-334.

[21]Pentheroudakis, G., Pavlidis, N., 2006. Cancer and pregnancy: poena magna, not anymore. Eur. J. Cancer, 42(2):126-140.

[22]Pentheroudakis, G., Orecchia, R., Hoekstra, H.J., et al., 2010. Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 21(Suppl. 5):v266-v273.

[23]Rabaiotti, E., Sigismondi, C., Montoli, S., et al., 2010. Management of locally advanced cervical cancer in pregnancy: a case report. Tumori, 96(4):623-626.

[24]Smyth, E.C., Korpanty, G., Mccaffrey, J.A., et al., 2010. Small-cell carcinoma of the cervix at 23 weeks gestation. J. Clin. Oncol., 28(18):e295-e297.

[25]Sood, A.K., Sorosky, J.I., 1998. Invasive cervical cancer complicating pregnancy. How to manage the dilemma. Obstet. Gynecol. Clin. North Am., 25(2):343-352.

[26]Stensheim, H., Moller, B., van Dijk, T., et al., 2009. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J. Clin. Oncol., 27(1):45-51.

[27]Takushi, M., Moromizato, H., Sakumoto, K., et al., 2002. Management of invasive carcinoma of the uterine cervix associated with pregnancy: outcome of intentional delay in treatment. Gynecol. Oncol., 87(2):185-189.